Cargando…

The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model

BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L i...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Cruz, Roseli, Camats, Maria, Calin, George A., Liu, Chang-Gong, Volinia, Stefano, Taccioli, Cristian, Croce, Carlo M., Bach-Elias, Montse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631104/
https://www.ncbi.nlm.nih.gov/pubmed/26138095
http://dx.doi.org/10.1186/s12881-015-0184-z
_version_ 1782398815234424832
author García-Cruz, Roseli
Camats, Maria
Calin, George A.
Liu, Chang-Gong
Volinia, Stefano
Taccioli, Cristian
Croce, Carlo M.
Bach-Elias, Montse
author_facet García-Cruz, Roseli
Camats, Maria
Calin, George A.
Liu, Chang-Gong
Volinia, Stefano
Taccioli, Cristian
Croce, Carlo M.
Bach-Elias, Montse
author_sort García-Cruz, Roseli
collection PubMed
description BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L is frequently detected in different tumours, which acts as constitutive activator of Ras functions and is considered to be a strong activating mutant. Additionally, a rare congenital disorder named Costello Syndrome, is described as a H-Ras disorder in children, mainly due to mutation G12S in p19 and p21 H-Ras proteins, which is present in 90 % of the Costello Syndrome patients. Our aim is to better understand the role of p19 and p21 H-Ras proteins in the cancer and Costello Syndrome development, concerning the miRNAs expression. METHODS: Total miRNAs expression regulated by H-Ras proteins were first analyzed in human miRNA microarrays assays. Previously selected miRNAs, were further analyzed in developed cell lines containing H-Ras protein mutants, that included the G12S Costello Syndrome mutant, with PCR Real-Time Taq Man miRNA Assays primers. RESULTS: This study describes how p19 affects the RNA world and shows that: i) miR-342, miR-206, miR-330, miR-138 and miR-99b are upregulated by p19 but not by p19W164A mutant; ii) anti-miR-206 can restore the G2 phase in the presence of p19; iii) p19 and p21Q61L regulate their own alternative splicing; iv) miR-206 and miR-138 are differentially regulated by p19 and p21 H-Ras and v) P19G12S Costello mutants show a clear upregulation of miR-374, miR-126, miR-342, miR-330, miR-335 and let-7. CONCLUSIONS: These results allow us to conclude that the H-Ras G12S mutation plays an important role in miRNA expression and open up a new line of study to understand the consequences of this mutation on Costello syndrome. Furthermore, they suggest that oncogenes may have a sufficiently important impact on miRNA expression to promote the development of numerous cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0184-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4631104
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46311042015-11-04 The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model García-Cruz, Roseli Camats, Maria Calin, George A. Liu, Chang-Gong Volinia, Stefano Taccioli, Cristian Croce, Carlo M. Bach-Elias, Montse BMC Med Genet Research Article BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L is frequently detected in different tumours, which acts as constitutive activator of Ras functions and is considered to be a strong activating mutant. Additionally, a rare congenital disorder named Costello Syndrome, is described as a H-Ras disorder in children, mainly due to mutation G12S in p19 and p21 H-Ras proteins, which is present in 90 % of the Costello Syndrome patients. Our aim is to better understand the role of p19 and p21 H-Ras proteins in the cancer and Costello Syndrome development, concerning the miRNAs expression. METHODS: Total miRNAs expression regulated by H-Ras proteins were first analyzed in human miRNA microarrays assays. Previously selected miRNAs, were further analyzed in developed cell lines containing H-Ras protein mutants, that included the G12S Costello Syndrome mutant, with PCR Real-Time Taq Man miRNA Assays primers. RESULTS: This study describes how p19 affects the RNA world and shows that: i) miR-342, miR-206, miR-330, miR-138 and miR-99b are upregulated by p19 but not by p19W164A mutant; ii) anti-miR-206 can restore the G2 phase in the presence of p19; iii) p19 and p21Q61L regulate their own alternative splicing; iv) miR-206 and miR-138 are differentially regulated by p19 and p21 H-Ras and v) P19G12S Costello mutants show a clear upregulation of miR-374, miR-126, miR-342, miR-330, miR-335 and let-7. CONCLUSIONS: These results allow us to conclude that the H-Ras G12S mutation plays an important role in miRNA expression and open up a new line of study to understand the consequences of this mutation on Costello syndrome. Furthermore, they suggest that oncogenes may have a sufficiently important impact on miRNA expression to promote the development of numerous cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0184-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-03 /pmc/articles/PMC4631104/ /pubmed/26138095 http://dx.doi.org/10.1186/s12881-015-0184-z Text en © García-Cruz et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
García-Cruz, Roseli
Camats, Maria
Calin, George A.
Liu, Chang-Gong
Volinia, Stefano
Taccioli, Cristian
Croce, Carlo M.
Bach-Elias, Montse
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title_full The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title_fullStr The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title_full_unstemmed The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title_short The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
title_sort role of p19 and p21 h-ras proteins and mutants in mirna expression in cancer and a costello syndrome cell model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631104/
https://www.ncbi.nlm.nih.gov/pubmed/26138095
http://dx.doi.org/10.1186/s12881-015-0184-z
work_keys_str_mv AT garciacruzroseli theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT camatsmaria theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT calingeorgea theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT liuchanggong theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT voliniastefano theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT tacciolicristian theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT crocecarlom theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT bacheliasmontse theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT garciacruzroseli roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT camatsmaria roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT calingeorgea roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT liuchanggong roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT voliniastefano roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT tacciolicristian roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT crocecarlom roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel
AT bacheliasmontse roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel